• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Whole Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 May Cause False-Positive Results in Serological Assays.

作者信息

Yamaoka Yutaro, Jeremiah Sundararaj S, Miyakawa Kei, Saji Ryo, Nishii Mototsugu, Takeuchi Ichiro, Ryo Akihide

机构信息

Department of Microbiology, Yokohama City University School of Medicine, Kanagawa, Japan.

Life Science Laboratory, Technology and Development Division, Kanto Chemical Co, Inc, Kanagawa, Japan.

出版信息

Clin Infect Dis. 2021 Apr 8;72(7):1291-1292. doi: 10.1093/cid/ciaa637.

DOI:10.1093/cid/ciaa637
PMID:32445559
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7314131/
Abstract
摘要

相似文献

1
Whole Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 May Cause False-Positive Results in Serological Assays.严重急性呼吸综合征冠状病毒2的全核衣壳蛋白可能在血清学检测中导致假阳性结果。
Clin Infect Dis. 2021 Apr 8;72(7):1291-1292. doi: 10.1093/cid/ciaa637.
2
False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV.在基于重组严重急性呼吸综合征相关冠状病毒（SARS-CoV）核衣壳的蛋白质印迹分析中，通过使用刺突蛋白的两个亚基（S1和S2）来检测抗SARS-CoV抗体，纠正了假阳性结果。
Clin Vaccine Immunol. 2006 Mar;13(3):409-14. doi: 10.1128/CVI.13.3.409-414.2006.
3
False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide.在重组严重急性呼吸综合征相关冠状病毒（SARS-CoV）核衣壳酶联免疫吸附测定中，因HCoV-OC43和HCoV-229E导致的假阳性结果，通过用重组SARS-CoV刺突多肽进行蛋白质免疫印迹法得以纠正。
J Clin Microbiol. 2004 Dec;42(12):5885-8. doi: 10.1128/JCM.42.12.5885-5888.2004.
4
The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development.严重急性呼吸综合征冠状病毒2的核衣壳蛋白：疫苗开发的一个靶点
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.00647-20.
5
From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.从 SARS 和 MERS CoVs 到 SARS-CoV-2：病毒结构和非结构基因中更偏向于使用密码子。
J Med Virol. 2020 Jun;92(6):660-666. doi: 10.1002/jmv.25754. Epub 2020 Mar 16.
6
Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus.严重急性呼吸综合征（SARS）冠状病毒所致肺炎患者针对SARS冠状病毒核衣壳蛋白的免疫球蛋白G（IgG）、IgM和IgA抗体的纵向变化情况
Clin Diagn Lab Immunol. 2004 Jul;11(4):665-8. doi: 10.1128/CDLI.11.4.665-668.2004.
7
Serological differentiation between COVID-19 and SARS infections.新冠病毒与 SARS 感染的血清学鉴别。
Emerg Microbes Infect. 2020 Dec;9(1):1497-1505. doi: 10.1080/22221751.2020.1780951.
8
[Molecular cloning and expression of the severe acute respiratory syndrome-associated coronavirus nucleocapsid protein and its clinical application].严重急性呼吸综合征相关冠状病毒核衣壳蛋白的分子克隆、表达及其临床应用
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005 Mar;19(1):64-7.
9
Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: implication for SARS diagnosis.严重急性呼吸综合征（SARS）冠状病毒核衣壳蛋白与I组动物冠状病毒多克隆抗血清之间的抗原交叉反应性：对SARS诊断的意义
J Clin Microbiol. 2004 May;42(5):2351-2. doi: 10.1128/JCM.42.5.2351-2352.2004.
10
Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia.严重急性呼吸综合征（SARS）冠状病毒刺突多肽酶联免疫吸附测定（ELISA）和SARS冠状病毒核衣壳蛋白ELISA在SARS冠状病毒肺炎血清学诊断中的差异敏感性。
J Clin Microbiol. 2005 Jul;43(7):3054-8. doi: 10.1128/JCM.43.7.3054-3058.2005.

引用本文的文献

1
Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories.通过核衣壳抗体轨迹聚类识别未检测到的新冠病毒感染
Nat Commun. 2025 May 14;16(1):4466. doi: 10.1038/s41467-025-57370-z.
2
Identification of B-Cell Linear Epitopes in the Nucleocapsid (N) Protein B-Cell Linear Epitopes Conserved among the Main SARS-CoV-2 Variants.鉴定核衣壳（N）蛋白中的 B 细胞线性表位 主要 SARS-CoV-2 变体中保守的 B 细胞线性表位。
Viruses. 2023 Apr 6;15(4):923. doi: 10.3390/v15040923.
3
A new multiplex SARS-CoV-2 antigen microarray showed correlation of IgG, IgA, and IgM antibodies from patients with COVID-19 disease severity and maintenance of relative IgA and IgM antigen binding over time.一种新的多重 SARS-CoV-2 抗原微阵列显示，COVID-19 疾病严重程度与患者的 IgG、IgA 和 IgM 抗体之间存在相关性，并且相对 IgA 和 IgM 抗原结合随时间推移而保持。
PLoS One. 2023 Mar 30;18(3):e0283537. doi: 10.1371/journal.pone.0283537. eCollection 2023.
4
The evaluation results of proposed antigen rapid diagnostic tests for COVID-19: some possible factors might influence.提出的 COVID-19 抗原快速诊断检测的评估结果：可能有一些因素会影响。
Infection. 2023 Oct;51(5):1285-1291. doi: 10.1007/s15010-022-01975-9. Epub 2023 Jan 2.
5
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
6
On the Need to Determine the Contribution of Anti-Nucleocapsid Antibodies as Potential Contributors to COVID-19 Convalescent Plasma Efficacy.关于确定核衣壳抗体的贡献作为 COVID-19 恢复期血浆疗效的潜在贡献的必要性。
Viruses. 2022 Oct 27;14(11):2378. doi: 10.3390/v14112378.
7
Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severity.针对甲型冠状病毒核衣壳蛋白的 IgG 反应与 COVID-19 严重程度的关联。
Front Immunol. 2022 Sep 7;13:889836. doi: 10.3389/fimmu.2022.889836. eCollection 2022.
8
Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins.SARS-CoV-2 中和抗体广谱性研究进展
Int J Mol Sci. 2022 Mar 10;23(6):2977. doi: 10.3390/ijms23062977.
9
Assessment of Diagnostic Specificity of Anti-SARS-CoV-2 Antibody Tests and Their Application for Monitoring of Seroconversion and Stability of Antiviral Antibody Response in Healthcare Workers in Moscow.评估抗SARS-CoV-2抗体检测的诊断特异性及其在监测莫斯科医护人员血清转化和抗病毒抗体反应稳定性中的应用。
Microorganisms. 2022 Feb 12;10(2):429. doi: 10.3390/microorganisms10020429.
10
Antigenic properties of the SARS-CoV-2 nucleoprotein are altered by the RNA admixture.SARS-CoV-2 核蛋白的抗原特性因 RNA 混合物而改变。
PeerJ. 2022 Jan 7;10:e12751. doi: 10.7717/peerj.12751. eCollection 2022.